Unraveling the IVIG mystique (Q48304490)

10 February 2018

editorial

0 references

title

Unraveling the IVIG mystique (English)

1 reference

10 February 2018

author name string

Donald R Branch

series ordinal

1 reference

10 February 2018

publication date

1 February 2013

1 reference

10 February 2018

published in

Transfusion

1 reference

10 February 2018

volume

1 reference

10 February 2018

issue

1 reference

10 February 2018

page(s)

242-244

1 reference

10 February 2018

History of immunoglobulin replacement

cites work

1 reference

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients

21 January 2018

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

21 January 2018

1 reference

Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).

21 January 2018

1 reference

Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders

21 January 2018

1 reference

Obstetric uses of intravenous immunoglobulin: successes, failures, and promises

21 January 2018

1 reference

Dermatological Uses of High-Dose Intravenous Immunoglobulin

21 January 2018

1 reference

New uses for IVIgG immunoglobulin therapies

21 January 2018

1 reference

Clinical uses of intravenous immunoglobulin.

21 January 2018

1 reference

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

The use of i.v. IG therapy in dermatology

21 January 2018

1 reference

Unlabeled uses of intravenous immune globulin

21 January 2018

1 reference

Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?

21 January 2018

1 reference

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

21 January 2018

1 reference

Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia

21 January 2018

1 reference

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.

21 January 2018

1 reference

Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?

21 January 2018

1 reference

Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

21 January 2018

1 reference

Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells

21 January 2018

1 reference

Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.12053

1 reference

10 February 2018

1 reference

10 February 2018